Accretion Pharmaceuticals Financials

NSE: ACCPL

₹200.00

₹-2.00 (-0.99%)

As on 04-Sep-2026 15:50IST

Market cap

₹222 Cr

Revenue (TTM)

₹90 Cr

P/E Ratio

23

P/B Ratio

4.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	89.63	57.38	13.35	--	--	--
Total Income	89.82	57.47	13.41	--	--	--
Total Expenditure	74.65	45.49	10.79	--	--	--
EBITDA	14.97	11.88	2.56	--	--	--
Depreciation	1.21	0.77	0.22	--	--	--
EBIT	13.76	11.11	2.34	--	--	--
Interest	0.87	1.44	0.40	--	--	--
Other Income	0.19	0.09	0.05	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	13.08	9.76	2.00	--	--	--
Provision for Tax	3.42	2.97	0.50	--	--	--
Profit after Tax	9.67	6.79	1.49	--	--	--

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	54.71	15.29	5.49	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.13	1.36	6.91	--	--	--
Current Liabilities	20.84	23.23	15.03	--	--	--
Total Liabilities	76.68	39.87	27.44	--	--	--

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	13.72	6.33	5.39	--	--	--
Current Assets	60.40	33.45	22.05	--	--	--
Total Assets	76.68	39.87	27.44	--	--	--
Total Debt*	12.32	14.10	13.48	--	--	--
Net Current Assets	39.56	10.22	7.02	--	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-14.53	-0.62	-11.51	--	--	--
Cash Flow from Investing Activities	-8.53	-1.61	-5.48	--	--	--
Cash from Financing Activities	27.04	2.19	17.08	--	--	--
Net Cash Inflow / Outflow	3.97	-0.04	0.09	--	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	8.70	8.32	1.96	--	--	--
Cash EPS (₹)	9.79	9.26	2.26	--	--	--
Adjusted Book Value (₹)	46.91	18.59	7.23	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-13.08	-0.76	-28.77	--	--	--
Free Cash Flow per Share (₹)	-21.66	-4.72	-46.69	--	--	--

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	29.77	46.42	12.62	--	--	--
ROE (%)	28.72	65.71	27.18	--	--	--
ROA (%)	16.59	20.18	5.44	--	--	--
EBIT Margin (%)	15.36	19.36	17.52	--	--	--
Net Margin (%)	10.76	11.82	11.13	--	--	--
Cash Profit Margin (%)	12.14	13.19	12.85	--	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	56.21	329.70	--	--	--	--
EBIT Growth (%)	23.91	374.78	--	--	--	--
Net Profit Growth (%)	42.31	355.08	--	--	--	--
EPS Growth (%)	4.59	323.34	--	--	--	--
Book Value Growth (%)	243.37	176.46	--	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	7.31	--	--	--	--	--
Price / Book Value	1.35	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	5.21	1.86	6.64	--	--	--
Close Price (₹)	63.55	--	--	--	--	--
High Price (₹)	102.50	--	--	--	--	--
Low Price (₹)	53.80	--	--	--	--	--
Market Cap (₹ Cr)	70.64	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.24	0.93	2.45	--	--	--
Short term debt to equity ratio	0.16	0.61	0.76	--	--	--
Current Ratio	2.90	1.44	1.47	--	--	--
Quick Ratio	1.54	0.55	0.50	--	--	--
Interest Coverage	16.03	7.79	6.00	--	--	--

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	24.99	20.32	43.47	--	--	--
Asset Turnover	1.54	1.70	0.49	--	--	--
Receivable days	69.36	55.55	158.67	--	--	--
Inventory Days	99.74	111.60	395.71	--	--	--
Payable days	37.40	64.77	256.34	--	--	--
Cash Conversion Cycle	131.70	102.38	298.04	--	--	--